MET Earnings

MET reported its FY2025Q4 earnings on 2026-02-04, showcasing a revenue of 0.00 against an estimate of 27.00B, resulting in a 0% surprise. The EPS was 0, surpassing the expected 2.36 by 0% . The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following MET's FY2025Q4 earnings announcement on 2026-02-04, the stock price moved by % on the day of the release. Over the subsequent five days, it saw a % change. Historically, MET's stock price tends to shift by an average of +0.03% in the 10 days leading up to earnings and -0.31% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate MET’s annual revenue to reach 31.00B, while the EPS is projected at 2.00. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Upward by 14.31% and EPS estimates Revise Upward by 64.25% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between MET's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were Revise Upward by 14.31%, while EPS estimates moved Revise Upward by 64.25% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, MET's stock price typically moves by +0.03% in the 10 days before its earnings and -0.31% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of 2.00 and revenue of 31.00B.

The earnings call highlights strong performance and strategic advancements, such as the successful Chariot Re launch and favorable financial ratios. The Q&A session reveals management's confidence in overcoming challenges, with positive updates on nonmedical health and MIM's growth. Despite some unclear responses, the overall sentiment is positive due to strategic initiatives like the PineBridge acquisition and efficient capital structures in Japan. The stock price is likely to experience a positive movement, within the 2% to 8% range, as the company demonstrates resilience and growth potential.